For organizationsSign inSign up
CMT Research Foundation
Join us Thursday, February 12, 2026 at 7pm ET for a live discussion with Daniel Brennan, NMD Pharma’s SVP of Corporate a
CMT Research FoundationFebruary 9, 2026

16 likes

Join us Thursday, February 12, 2026 at 7pm ET for a live discussion with Daniel Brennan, NMD Pharma’s SVP of Corporate and Commercial Strategy.

This is a webinar you should not miss. We are sharing an update from @nmdpharma regarding topline results from their Phase 2a clinical study called SYNAPSE-CMT. This clinical study explored whether the new, investigational drug ignaseclant (formerly NMD670), could provide benefit adults with Charcot-Marie-Tooth disease (CMT) type 1 and type 2. The CMTRF is optimistic about what ignaseclant and the results of the clinical trail could mean for the CMT patient community. Register at cmtrf.org/webinars
CMTRF org
See it on Instagram ↗
More from CMTRF org
We made the 2026 Global CMT Research Convention available for everyone! Browse every talk at cmtconvention.cmtrf.org.We made the 2026 Global CMT Research Convention available for everyone!Nov 221 likesWe've got a data tool that's going to make CMT research faster and cheaper. Come hear about it! cmtrf.org/webinarsWe've got a data tool that's going to make CMT research faster and cheaper.Oct 1516 likesInterested in the Global CMT Research Convention in September? We've got a webinar coming up on August 6th to break downInterested in the Global CMT Research Convention in September?Aug 453 likesThinking about attending the 2026 Global CMT Research Convention? Our CEO Laura MacNeill explains what you can get out oThinking about attending the 2026 Global CMT Research Convention?Jul 3014 likesAs the number of gene therapies in trials for CMT continues to grow, how those gene therapies are regulated will becomeAs the number of gene therapies in trials for CMT continues to grow…Jul 1317 likesWe've highlighted the promise of gene therapies in our DEMYSTIFIED webinar series. It concludes on July 16 with a discusWe've highlighted the promise of gene therapies in our DEMYSTIFIED webinar series.Jul 717 likesRegister to learn about how gene therapies are regulated and how you can help shape the future. cmtrf.org/webinarsRegister to learn about how gene therapies are regulated and how you can help shape the…Jul 120 likesGene therapy programs are showing real promise, especially for genetic diseases like CMT. Learn more through our Gene ThGene therapy programs are showing real promise, especially for genetic diseases like CMT.Jun 1751 likesOur GENE THERAPIES DEMYSTIFIED series starts May 7; sign up at cmtrf.org/webinars and bring your questions!Our GENE THERAPIES DEMYSTIFIED series starts May 7…Apr 2353 likesSign up at cmtrf.org/webinars!Sign up at cmtrf.org/webinars!Apr 1723 likesThe CMT Research Foundation is funding a novel digital-endpoint project with Dr. Wolfgang Pernice at Columbia UniversityThe CMT Research Foundation is funding a novel digital-endpoint project with Dr.Feb 2019 likesThe CMT Research Foundation congratulates NMD Pharma and, above all, the 81 individuals who took part in the Phase 2a SYThe CMT Research Foundation congratulates NMD Pharma and, above all…Feb 337 likes
More from CMT Research Foundation
Country Music Superstar Alan Jackson, who has been open about his diagnosis with CMT, is wrapping up his career with a fCountry Music Superstar Alan Jackson, who has been open about his diagnosis with CMT…May 1963 likesTHANK YOU to @officialalanjackson Jackson and the Last Call Tour for the years of support of CMT research!THANK YOU to @officialalanjackson Jackson and the Last Call Tour for the years of support…Jun 2960 likesCongratulations to Dr. Marina Kennerson, the winner of the 2026 Pathfinder Award for her leadership and contributions toCongratulations to Dr.Sep 2543 likesHow can CMT patients get involved in research? The convention in September is a great start, but Early Bird RegistrationHow can CMT patients get involved in research?Jun 1732 likesA well-deserved standing ovation for our 2026 Catalyst Award Winner, Susan Ruediger, our Chief Mission Officer and Co-foA well-deserved standing ovation for our 2026 Catalyst Award Winner, Susan Ruediger…Sep 2630 likesIt starts today! Looking forward to discussion on the most advanced and pressing questions in CMT research.It starts today!Sep 2428 likesSeptember is CMT Action Month, and that means it's also time for the Global CMT Research Convention. CEO Laura MacNeillSeptember is CMT Action Month, and that means it's also time for the Global CMT Research…Sep 126 likesThe Zero K Fundraiser Run was a huge success, and we look forward to using the funds for driving CMT research toward a cThe Zero K Fundraiser Run was a huge success, and we look forward to using the funds for…Jun 126 likesFinding a reliable blood-based marker would make clinical trials more efficient and give doctors a straightforward way tFinding a reliable blood-based marker would make clinical trials more efficient and give…Mar 2726 likesGaining Velocity Toward a World Without CMT: A Message from CEO and Board Chair of CMTRF: https://cmtrf.org/year-in-reviGaining Velocity Toward a World Without CMT: A Message from CEO and Board Chair of CMTRF…Jan 524 likesOne of the greatest barriers to developing therapies for Charcot-Marie-Tooth (CMT) disease has been the lack of sensitivOne of the greatest barriers to developing therapies for Charcot-Marie-Tooth (CMT)…Feb 2623 likesThere are only a few hours left in 2025, and time is running out to make your tax-deductible, year-end donation to suppoThere are only a few hours left in 2025, and time is running out to make your…Dec 31, 202523 likes